HRTX – heron therapeutics, inc. (US:NASDAQ)

News

Heron Therapeutics (HRTX) was upgraded by Zacks Research from "strong sell" to "hold".
Heron Therapeutics (HRTX) was downgraded by Zacks Research from "hold" to "strong sell".
Heron Therapeutics, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Heron Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]
Heron Therapeutics, Inc. (HRTX) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com